Risk factors for gestational diabetes mellitus
The exact mechanism underlying GDM is not yet fully elucidated, although it is speculated that women who develop GDM may have underlying insulin resistance and genetic susceptibility. [4] GDM is reported to affect ~14% of pregnancies globally; however, rates between 1% and 28% are reported in different regions and vary according to ethnicity, [5] geographical location (urban v. rural), [6] environmental factors and screening and diagnostic strategies employed. [7] In the USA, for example, the prevalence of GDM was reported to be 11.1% in Asian Indians and 4.1% in non-Hispanic whites, [5] while in Tanzania, the prevalence of GDM was 1% and 8.4% in a rural and urban setting, respectively. [6] Although data are scant, the prevalence of GDM in SA is estimated to be 1.6 -25.8%, based on various screening and diagnostic strategies employed. [8, 9] Other definable risk factors that affect GDM prevalence include advanced maternal age, overweight and obesity, family history of diabetes, previous history of GDM and previous adverse pregnancy outcomes (Table 1) . [10] Alarmingly, the rate of obesity is increasing dramatically, with SA now regarded as one of the world's most obese nations. [11] According to recent statistics, ~69% of SA women are overweight or obese. [3] The increasing risk of obesity is largely due to changes in lifestyle, which have contributed to the increasing prevalence of T2D and metabolic syndrome, particularly among females. [11] Although universal screening, whereby all pregnant women undergo the diagnostic 75 g oral glucose tolerance test (OGTT) at 24 -28 weeks of gestation, has been widely advocated as Gestational diabetes mellitus (GDM) is associated with adverse maternal, fetal and perinatal complications. Without appropriate glucose management, women with GDM and their offspring have an increased risk of developing type 2 diabetes and other metabolic conditions later in life, thereby adding to the growing burden of non-communicable diseases (NCDs). This review provides an update of GDM in South Africa (SA), showing that its prevalence is increasing, and highlights treatment and management strategies currently employed. Although the increase in GDM prevalence may partly be due to less stringent diagnostic criteria, the role of the increasing obesogenic environment in SA is an additional factor. Future research should focus on reducing the rising obesity epidemic and in so doing aim to prevent the development of GDM in SA. Such initiatives will have a positive impact on decreasing maternal and child morbidity and mortality and the future burden of NCDs. [5] CME the recommended screening strategy for GDM, [12] selective screening based on risk factors is now predominantly used in SA, as it is considered less costly than subjecting all women to laboratory testing. However, risk factor-based selective screening has been found to have poor sensitivity and specificity in many studies, [13, 14] including our study, [9] and performs poorly as a screening tool for GDM. Moreover, selective screening places a high demand on healthcare workers to identify patients who should be screened and is often poorly adhered to, leading to inadequate screening and testing of GDM.
HIV and gestational diabetes mellitus
SA has the highest burden of HIV globally, with 7.1 million people living with the virus, [15] and ~19% of adults (15 -49 years of age) affected by the disease. [16] HIV infection and antiretroviral therapy dysregulate glucose metabolism and are associated with an increased risk of glucose intolerance and metabolic disease. [17] [18] [19] There is evidence that antiretroviral therapy, particularly first-generation protease inhibitors, induces insulin resistance in both pregnant and non-pregnant women. [20] The risk of developing GDM is shown to be more common in HIV-infected women receiving combined antiretroviral therapy, especially with protease inhibitors. [21, 22] Although protease inhibitors have been replaced by non-nucleoside reverse transcriptase inhibitors, which are considered safer, they too affect glucose homeostasis, [23] thus requiring further investigation. Current data in SA show no association between HIV infection and antiretroviral therapy and GDM. [9] Complications of gestational diabetes mellitus GDM is associated with adverse short-and long-term pregnancy outcomes in mothers and their offspring ( Table 2) . A study of 57 629 women with GDM reported that the prevalence of caesarean delivery, macrosomia, preterm birth and pre-eclampsia was 27.8%, 15.7%, 8.4% and 2.6%, respectively. [24] Fetal macrosomia is a common adverse obstetric outcome, affecting ~15 -45% of neonates born to women with GDM, and is associated with an increased risk of caesarean delivery, shoulder dystocia, birth injury, respiratory distress syndrome and neonatal hypoglycaemia. [25, 26] Furthermore, ~50% of women with GDM will develop T2D within 10 years, [27] while evidence increasingly shows that women with GDM have a 56%
higher risk of developing cardiovascular disease [28] and an increasing risk of metabolic syndrome later in life. [29] GDM is associated with an abnormal intrauterine environment that negatively affects the long-term health of offspring, possibly through epigenetic changes. It is estimated that children born to mothers with GDM have an 8-fold increased risk of developing T2D and prediabetes compared with children born to mothers with normoglycaemic pregnancies. [30] Treatment of GDM improves outcome; therefore, early detection and appropriate management are critical to prevent pregnancy complications. However, a challenge that hampers the early detection and management of GDM is the current lack of global consensus on GDM screening and diagnosis, which varies between countries and institutions. A recent study conducted by Meek et al. [31] found that women who were diagnosed with GDM according to the stringent International Association of Diabetes in Pregnancy Study Groups (IADPSG) criteria, but were missed when using the National Institute for Health and Care Excellence (NICE) criteria, had a substantial risk of obstetric complications, such as macrosomia, caesarean section and polyhydramnios.
Prevalence of gestational diabetes mellitus in South Africa
SA is undergoing an epidemiological transition characterised by an increase in NCDs due to urbanisation, nutritional transition towards a diet consisting of high fat and refined sugars and sociocultural factors involving perception of overweight as a measure of success and beauty. Approximately 69% of SA women are overweight, 40% are obese and 20% are morbidly obese, [3, 32] and are considered among the most overweight women globally, particularly those of reproductive age. Accordingly, GDM has rapidly increased in SA, with the prevalence ranging from 1.6% to 25.8% between 1969 and 2018 ( Table 3 ). The first GDM prevalence study was conducted in 1969 among Indian women from KwaZulu-Natal Province using the 100 g OGTT. A prevalence of 23.8% and 8.3% was reported in women with and without risk factors, respectively. [33] In 1979, using risk-factor screening and the 50 g OGTT, a GDM prevalence of 3% was reported in women of mixed ethnic ancestry in Western Cape Province. [34] Using the World Health Organization (WHO) 1985 diagnostic criteria, Ranchod et al., [8] in KwaZulu-Natal, reported a GDM prevalence of 1.6% and 3.8% in women of Indian and Jackson and Coetzee [34] (1979) Ranchod et al. [8] (1991) Mamobolo et al. [35] ( Basu et al. [36] (2010) Mixed Adam and Rheeder [9] (2017) Macaulay et al. [37] (2018) Normal calculated as the mean (2 SD); all values outside the range were considered as GDM. [38] ‡ Institutional protocol using capillary blood. § Selective testing refers to risk factor screening: advanced maternal age, obesity, family history of diabetes mellitus, glycosuria, certain ethnicities and prior adverse pregnancy outcomes. CME mixed ethnic ancestry, respectively. [8] A population-based study conducted in rural Limpopo Province reported a GDM prevalence of 8.8% in black women, using the WHO 1999 diagnostic criteria, [35] while a study of overweight and obese pregnant women of mixed ethnic ancestry in Johannesburg, Gauteng Province, showed a GDM prevalence of 1.8% using random and fasting glucose concentrations. [36] More recently, using the IADPSG criteria, a high prevalence of GDM (25.8%) was reported in black women from Johannesburg. [9] To date, the largest GDM prevalence study in SA found a prevalence of 9.1% in black women from Johannesburg, using the revised WHO 2013 diagnostic criteria, which are similar to the IADPSG criteria. [37] Disparities in the prevalence of GDM were observed between the abovementioned studies, which may be due to the different screening and diagnostic criteria. More recent studies, using the less stringent IADPSG [9] or WHO 2013 [37] criteria, show an increased prevalence of GDM compared with older criteria, which used higher glucose thresholds. [8, [33] [34] [35] [36] Thus, although the increased prevalence of GDM may partly be due to diagnostic criteria, the role of the increasing obesogenic environment in SA should not be underestimated. [3] Other factors, such as geographical setting, maternal age and population and environmental differences, could also account for the disparities in prevalence across studies. [9, 35, 37] 
Treatment
Management and treatment of GDM are important to reduce adverse pregnancy outcomes and improve maternal and neonatal health. [39] In SA, pregnant women with GDM are referred to the nearest secondary or tertiary hospital for management and treatment. [40] At the tertiary level, management of GDM is through counselling and health education provided by obstetricians, endocrinologists, dieticians or nurse educators. The primary form of intervention for women with GDM is lifestyle modification, which involves counselling regarding diet and physical activity. A dietary meal plan is provided, which entails reduced sugar and starch intake, increased protein intake and reduced total calorie intake. [40] However, in disadvantaged settings, these lifestyle changes are difficult to adhere to owing to the high cost of healthy food and lack of understanding and social support. A more sustainable approach is to counsel patients on how to reduce the glycaemic index of staple foods. The glycaemic index of carbohydrate-rich foods (e.g. potatoes, pap, pasta, rice) can be reduced by cooking, cooling and reheating, or by adding fats or acids such as lemon juice or vinegar. [41] Pharmacological therapy is initiated for women who fail to reach their glucose targets using diet and exercise. In SA, metformin is the drug of choice to treat GDM, while glyburide is used when metformin and insulin are not available. Although insulin is invasive and used only if metformin fails, it is effective, allows tight glucose control and is considered safe, as it does not cross the placenta. Generally, oral agents are preferred to insulin because of ease of administration, although studies conducted in other settings showed no substantial differences in major outcomes when comparing their benefits and risks. [42, 43] 
Current perspectives and future recommendations
• The rate of obesity is rising dramatically, thus increasing the prevalence of GDM globally and in SA.
• Untreated GDM negatively affects maternal and child health.
• GDM increases the risk of developing T2D and other NCDs later in life.
• Future research should focus on reducing obesity and preventing the development of GDM.
Conclusions
The prevalence of GDM is rapidly increasing in SA and is becoming a major public health concern. Without appropriate glucose management, GDM is associated with adverse pregnancy outcomes and an increased risk of future metabolic conditions in mothers and their offspring, further contributing to the growing burden of NCDs. Although the significant increase in the prevalence of GDM observed in recent SA studies may be attributed to the lower diagnostic thresholds used, the role of the increasing obesogenic environment should not be underestimated. Future research should focus on reducing the rising obesity epidemic and in so doing aim to prevent the development of GDM. Such initiatives will have a positive impact on decreasing maternal and child morbidity and mortality and the future burden of NCDs.
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